Fireside Chat: Driving Innovation through Equity, Diversity, and Inclusion at the County

September 24, 2024

3:00 pm

-

4:00 pm

Inclusion Alcove

This fireside chat brings together three key leaders from the County of San Diego to discuss how innovation, equity, diversity, and inclusion (EDI) intersect in the County’s initiatives. The conversation will explore the County’s approach to EDI in public services, community engagement, workforce development, and contracting. Attendees will gain insights into how the County ensures equitable opportunities for small businesses, supports diverse communities, and integrates EDI into its innovation strategies.

Chiara Leroy

Equity Impact Manager at the County of San Diego Office of Equity and Racial Justice

Sheena Figueroa

Chief of Procurement Services at the County of San Diego Department of Purchasing and Contracts

Steve Lockett

Deputy Director of Economic Development & Prosperity at the County of San Diego Office of Economic Development and Government Affairs

Taryell Simmons

Interim Director of the County of San Diego Office of Equity and Racial Justice

More Sessions

Attracting Capital for Cleantech Companies

3:30 pm

-

4:30 pm

Cleantech Alcove

Hear firsthand from cleantech investors about what they look for in investment opportunities. Panelists will share their perspectives on emerging cleantech innovations and their outlooks on the current investment landscape. Moderated by Zac Dobbin.

VC Chat with Franklin Templeton

3:45 pm

-

4:30 pm

The Beach

Hear from a variety of venture capital representatives and other investors as they talk about the state of the venture market and what advice and support they can give to San Diego’s innovation community.

San Diego’s RNA Cluster – Powering Public Health and the Economy

2:30 pm

-

3:30 pm

Life Science Alcove

San Diego County is the premier location for RNA therapeutics. Stephanie Ramos from TriLink moderates a panel of local experts, and shares a forum for continual education highlighting the positive impact of RNA medicines on public health.